international pharmaceutical compliance congress
international pharmaceutical compliance congress
international pharmaceutical compliance congress
international pharmaceutical compliance congress
international pharmaceutical compliance congress
international pharmaceutical compliance congress
Press Release: Int'l Pharma and Medical Device Compliance Congress XI Features Risk Assessments and Monitoring Plans
  • Sponsored by ETHICS, the International Society of Healthcare Compliance Professionals
  • Co-sponsored by the Pharmaceutical Compliance Forum
  • May 15 - 17, 2017
  • Onsite at the Lisbon Marriott Hotel, Lisbon, Portugal
  • www.InternationalPharmaCongress.com
PRESS RELEASE
Phone: 800-503-8171
Email: registration@hcconferences.com
Website: www.InternationalPharmaCongress.com
EARLY BIRD REGISTRATION
- SAVE UP TO €400 -
Register by Friday, March 10, 2017 and save up to €400.
Click here to register.

FEATURING RISK ASSESSMENTS AND MONITORING PLANS, PARTS I & II BY

Sue Egan
Director and Principal Consultant, Sue Egan Associates, Former Vice President Compliance, AstraZeneca, Great Missenden, Buckinghamshire, UK

Michael Alan Gleave
Compliance Officer, Corporate Compliance and CSR, H. Lundbeck A/S, Copenhagen, Denmark

Carl Judge
Partner, Fraud Investigation & Dispute Services, EY, London, UK

Anita K. Kim-Reinartz
Partner, Fraud Investigation & Dispute Services, EY, Düsseldorf, Germany

Maria-Teresa Rico Pérez, MD
Europe and Canada Regional Compliance Officer, Biogen, Zug, Switzerland

Jose Manuel Garcelan
Global Compliance Consultant, Chemo, Former Regional Compliance and Privacy Officer, Merck, Sharp, and Dohme, Madrid, Spain

Gabriela Radu
Compliance Lead and Data Privacy Officer, Amgen Romania, Former Ethics and Compliance Associate, Eli Lilly and Company, Bucharest, Romania

Jolanta Wyszynska
Vice President, Compliance Europe, AstraZeneca, Warsaw, Poland

Abdul Luheshi, MBA
Executive Director, Global Operations, Ethics & Compliance, Astellas Pharma EMEA, Former Vice President, Health Care Compliance, Johnson & Johnson, Former Co-chair, Asia Pacific Pharma Compliance Congress, Chertsey, UK (Moderator)

LISBON, PORTUGAL -- PHARMA UPDATE NEWS SERVICE™ -- FEBRUARY 1, 2017: The Eleventh International Pharmaceutical and Medical Device Compliance Congress, www.InternationalPharmaCongress.com, to be held May 15 - 17, 2017 at the Lisbon Marriott Hotel in Lisbon, Portugal, today announced the conference dates and a call for proposals.

CO CHAIRS

Dante Beccaria
Global Compliance Officer and Vice President, Sanofi, Former Vice President of Internal Audit, Sanofi, Paris, France

Stephen Nguyen Duc
Office of Ethics & Compliance Area Director, International Operations, Western Europe & Canada, AbbVie, Board Member, Strategic Committee International Society of Healthcare, Ethics, and Compliance Professionals (ETHICS), Rungis, France

Dominique Laymand, Esq.
Senior Vice President, Chief Ethics and Compliance Officer, Ipsen; President, International Society of Healthcare Ethics and Compliance Professionals (ETHICS), Paris, France

Roeland Van Aelst
Regional Vice President - HCCO MD&D EMEA & Canada, Office Health Care Compliance and Privacy, Johnson & Johnson, Co-chair, Strategic Committee, International Society of Healthcare, Ethics and Compliance Professionals (ETHICS), Chairman, MedTech Compliance Network, Brussels, Belgium

FEATURING CHIEF COMPLIANCE OFFICERS

Timothy Ayers, JD, MPH
Vice President, Chief Compliance Officer, Horizon Pharma PLC, Former Vice President, Chief Compliance Officer, Dendreon, Former Associate General Counsel; Executive Director of Compliance, Seattle Genetics, Chicago, IL, USA

Sujata Dayal, JD
Vice President, Health Care Compliance and Privacy, Global Chief Compliance Officer, Pharmaceuticals, Johnson and Johnson, Former Chief Compliance Officer and Corporate Vice President, Biomet, Inc., Former Ethics and Compliance Officer, Abbott Laboratories, Titusville, NJ, USA

Martin Fuerle, MBA
General Counsel and Chief Compliance Officer, Vice President Risk & Compliance, Daiichi Sankyo Europe GmbH, Munich, Germany

Lori V. Queisser, CPA
Senior Vice President and Global Compliance Officer, Teva Pharmaceuticals, Philadelphia, PA, USA

Uffe Kåre Rasmussen, M.Sc.
Senior Director and Chief Compliance Officer, H. Lundbeck A/S, Former Principal Scientist, Novo Nordisk A/S, Copenhagen, Denmark

FEATURED FACULTY

Ted Acosta, Esq.
Americas Vice Chair, Risk Management, EY; Former Senior Counsel, Office of Inspector General, United States Department of Health and Human Services, New York, NY, USA and Paris, France

David Andersen
Partner, Pharmaceuticals and Life Sciences, PwC, London, UK

Dr. Michael Bartke
Former, Director Compliance Management, Daiichi Sankyo Europe GmbH, Munich, Germany

Ann Beasley
Director - Healthcare and Life Sciences Disputes, Compliance & Investigations, Navigant Consulting, Former Chief Compliance Officer, Biogen, Former Global Compliance Officer, Novartis, Boston, MA, USA

Andy Bender, MS, MBA
President and Founder, Polaris, New York, NY, USA

Peter W.L. Bogaert, MA, LJ
Partner, Covington & Burling LLP, Brussels, Belgium

Chrissy Bradshaw, JD
Attorney, Porzio Bromberg & Newman, Morristown, NJ, USA

Anne-Sophie Bricca
Deputy General Counsel, Senior Director Law and Compliance, EMEA, Terumo BCT, Brussels, Belgium

Anna Byrom, LLM
Associate Director, Compliance EUCA, Intercept Pharmaceuticals, Former Associate Director, Astellas Pharma Europe, London, United Kingdom

Jeffrey Campbell, JD
President and Chief Executive Officer, Porzio Life Sciences, Porzio Life Sciences, LLC, Morristown, NJ

Holger Diener, PhD
Managing Director, Association of Voluntary Self-Regulation for the Pharmaceutical Industry, Berlin, Germany

Peter Dieners, Esq.
Partner and Head, Global Healthcare and Life Sciences Group, Clifford Chance, Co-chair, Legal Affairs Focus Group (LA FG), EUCOMED, Co-chair, Compliance Network (CN), EUCOMED, Düsseldorf, Germany

Sue Egan
Director and Principal Consultant, Sue Egan Associates, Former Vice President Compliance, AstraZeneca, Great Missenden, Buckinghamshire, United Kingdom

George Fife
Executive Director, Fraud Investigation & Dispute Services, EY; Former Executive Director, Compliance & Ethics, Bristol-Myers Squibb, Paris, France

Jose Manuel Garcelan
Global Compliance Consultant, Chemo; Former Regional Compliance and Privacy Officer, Merck, Sharp, and Dohme; Madrid, Spain

Dominik Geller
Head Pharma Healthcare Compliance Office, Roche, Basel, Switzerland

Gary F. Giampetruzzi, Esq.
Partner, Paul Hastings, Former Vice President and Assistant General Counsel, Head of Government Investigations, Pfizer Inc., New York, NY, USA

Michael Alan Gleave
Compliance Officer, Corporate Compliance and CSR, H. Lundbeck A/S, Copenhagen, Denmark

Cécile Gousset
Associate Vice President, Compliance Risk Assessment, Education and Monitoring, Global Ethics & Business Integrity, Sanofi, Paris, France

Ulf H. Grundmann, Esq.
Partner, Life Sciences Practice Group, King & Spalding LLP, Frankfurt am Main, Germany

Joe Henein, Pharm.D.
President and Chief Executive Officer, NewBridge Pharmaceuticals FZ LLC, Dubai, United Arab Emirates

Chris J Holmes
Director, Healthcare and Life Sciences Disputes, Regulatory, Compliance and Investigations, Navigant, London, United Kingdom

Casey Horton
Director, Healthcare and Life Sciences Disputes, Regulatory Compliance and Investigations, Navigant, Chicago, IL, USA

Bella Rafael Hovhannisyan
Compliance and Ethics Lead, Spain, Portugal, and Nordic Region, Bristol-Myers Squibb, Madrid, Spain

Rajiv Joshi, ICAI, ISACA, CIA, CFE
Partner, Fraud Investigation & Dispute Services, EY, Mumbai, India

Carl Judge
Partner, Fraud Investigation & Dispute Services, EY, London, UK

Anita K. Kim-Reinartz
Partner, Fraud Investigation & Dispute Services, EY, Düsseldorf, Germany

Keith M. Korenchuk, JD, MPH
Partner, Arnold & Porter LLP, Washington, DC, USA

Kirtis Kraeuter, MGA
Head, Worldwide Compliance Committee and Monitoring Center of Expertise, Bristol-Myers Squibb, Princeton, NJ, USA

Evelyne Lemaire
Head of Compliance, Europe & Canada, Takeda Pharmaceuticals International GmbH, Former Director, Global Pharmaceutical and Life Sciences, PwC LLP, Zurich, Switzerland

William Long, LLB
Partner, Sidley Austin LLP, London, United Kingdom

Michael K. Loucks, JD
Partner, Skadden Arps LLP; Former Acting United States Attorney, District of Massachusetts, United States Department of Justice, Washington, DC

Abdul Luheshi, MBA
Executive Director, Global Operations, Ethics & Compliance, Astellas Pharma EMEA, Former Vice President, Health Care Compliance, Johnson & Johnson, Former Co-chair, Asia Pacific Pharma Compliance Congress, Chertsey, UK

Maureen McGirr, JD
Vice President, Office of Ethics, Global Compliance Organization, Merck, Sharp, and Dohme, Kenilworth, NJ, USA

Sofie Melis
Senior Manager, Ethics and Compliance, International Federation of Pharmaceutical Manufacturers and Associations (IFPMA), Geneva, Switzerland

Paul J. Melling, Esq.
Founding Partner, Baker & McKenzie - CIS, Limited, Moscow, Russia


Audrey Mills, JD
Sr. Director Ethics and Compliance and Chief Privacy Officer, Eli Lilly and Company, Indianapolis, IN, USA

Laura Nassar
Head of Compliance, Middle East, Roche Pharmaceuticals, Dubai, United Arab Emirates

David O'Shaughnessy
Vice President, Compliance, Emerging Markets, Quintiles, Board Member, ETHICS, Former Vice President Compliance, International Pharmaceuticals, GSK, Former Vice President, Global Compliance Strategy, AstraZeneca, Reading, UK

Giota Papamarkou
Global Ethics & Compliance Director, Ipsen, Former EMEA Compliance and Ethics Manager, Bristol-Myers Squibb, Paris, France



Oscar Perdomo
Director, Pharmaceuticals and Life Sciences, PwC, Switzerland

Maria-Teresa Rico Pérez, MD
Europe and Canada Regional Compliance Officer, Biogen, Zug, Switzerland

Ariadna Quesada, MPP
Compliance Manager Europe, Middle-East and Africa, MicroPort Orthopedics Inc., Amsterdam, Netherlands

Gabriela Radu
Compliance Lead & Data Privacy Officer at Amgen Romania; Former Ethics and Compliance Associate, Eli Lilly and Company, Bucharest, Romania

Jose Ramos, MBA
Compliance Officer for Italy, Portugal, and Spain, Biogen, Former Ethics and Compliance Officer, Eli Lilly, Madrid, Spain

Vivian Robinson, Esq.
Queen's Counsel, Partner, McGuire Woods, Former General Counsel of the UK Serious Fraud Office, Former Head, QEB Hollis Whiteman Chambers, Recorder of the Crown Court and Former Treasurer of Inner Temple, London, UK

Fabien Roy, DESS
Senior Associate, Hogan Lovells, Member, EFGCP-MedTech Europe Working Party, Brussels, Belgium

Brian Sharkey, JD
Vice President, Porzio Life Sciences, LLC, Morristown, NJ, USA

Heather Simmonds
Director, Prescription Medicines Code of Practice Authority, London, United Kingdom

Michele Tagliaferri, Esq.
Partner, Sidley Austin LLP, Brussels, Belgium

Melda Tanyeri, MS, MBA
Director, Fraud Investigation & Dispute Services, EY, London, UK

Yuet Ming Tham, JD
Partner, Sidley Austin LLP; Former Asia Pacific Regional Compliance, Director, Pfizer; Former Deputy Public Prosecutor, Singapore, Hong Kong

Frank Wartenberg, PhD
President, Central Europe, IMS Health, Lecturer, Health Care Management Institute, EBS Business School, Frankfurt/Main, Germany

Mariusz Witalis
Partner, Fraud Investigation and Dispute Services, Ernst & Young LLP, Warsaw, Poland

Elisabethann Wright, Esq.
Partner, Hogan Lovells International LLP, Brussels, Belgium

Jolanta Wyszynska
Vice President, Compliance Europe, AstraZeneca, Warsaw, Poland

Jose F. Zamarriego Izquierdo, PhD
Director Unidad de Supervision Deontologica, Farmainidustria, Madrid, Spain

EFPIA CODES TRAINING WORKSHOP
The European Federation of Pharmaceutical Industries and Associations (EFPIA) is offering an independent EFPIA CODES TRAINING WORKSHOP on Monday, May 15, 2017.

2017 INTERNATIONAL PHARMA CONGRESS PLANNING COMMITTEE
CO-CHAIRS
Dante Beccaria
Global Compliance Officer and Vice President, Sanofi, Former Vice President of Internal Audit, Sanofi, Paris, France

Stephen Nguyen Duc
Office of Ethics & Compliance Area Director, International Operations, Western Europe & Canada, AbbVie, Board Member, Strategic Committee International Society of Healthcare, Ethics, and Compliance Professionals (ETHICS), Rungis, France

Dominique Laymand, Esq.
Senior Vice President, Chief Ethics and Compliance Officer, Ipsen, President, International Society of Healthcare Ethics and Compliance Professionals (ETHICS), Paris, France

Roeland Van Aelst
Regional Vice President - HCCO MD&D EMEA & Canada, Office Health Care Compliance and Privacy, Johnson & Johnson, Co-chair, Strategic Committee, International Society of Healthcare, Ethics and Compliance Professionals (ETHICS), Chairman, MedTech Compliance Network, Brussels, Belgium
MEMBERS
Timothy Ayers, JD, MPH
Vice President, Chief Compliance Officer, Horizon Pharma PLC, Former Vice President, Chief Compliance Officer, Dendreon, Former Associate General Counsel; Executive Director of Compliance, Seattle Genetics, Chicago, IL, USA

Dr. Michael Bartke
Former Director Compliance Management, DAIICHI SANKYO EUROPE GmbH, Munich, Germany

Ann Beasley
Director - Healthcare and Life Sciences Disputes, Compliance & Investigations, Navigant Consulting, Former Chief Compliance Officer, Biogen, Former Global Compliance Officer, Novartis, Boston, MA, USA

Andy Bender, MS, MBA
President and Founder, Polaris, New York, NY, USA

Leonardo Cassara A. Silva, LLM
Global Compliance Officer, Ferring International Center S.A., Former Head of Compliance, Acino Pharma AG, Former Compliance Director, Emerging Markets, Takeda Pharmaceuticals, Saint-Prex, Switzerland

Sujata Dayal
Vice President, Health Care Compliance and Privacy, Global Chief Compliance Officer, Pharmaceuticals, Johnson & Johnson, Former Chief Compliance Officer and Corporate Vice President, Biomet, Inc.,Former Ethics and Compliance Officer, Abbott Laboratories, Titusville, NJ, USA

Sue Egan
Director and Principal Consultant, Sue Egan Associates, Former Vice President Compliance, AstraZeneca, Great Missenden, Buckinghamshire, UK

Martin Fuerle, MBA
General Counsel and Chief Compliance Officer, Vice President Risk & Compliance, Daiichi Sankyo Europe GmbH, Munich, Germany

Gary F. Giampetruzzi, Esq.
Partner, Paul Hastings, Former Vice President and Assistant General Counsel, Head of Government Investigations, Pfizer Inc., New York, NY, USA

Ulf H. Grundmann, Esq.
Partner, King and Spalding, Frankfurt am Main, Germany

Kirtis Kraeuter, MGA
Head, Worldwide Compliance Committee and Monitoring Center of Expertise, Bristol-Myers Squibb, Princeton, NJ, USA

Evelyne Lemaire
Head of Compliance, Europe & Canada, Takeda Pharmaceuticals International GmbH, Former Director, Global Pharmaceutical and Life Sciences, PwC LLP, Zurich, Switzerland

Maureen McGirr, JD
Vice President, Office of Ethics, Global Compliance Organization, Merck, Sharp, and Dohme, Kenilworth, NJ, USA

Paul J. Melling, Esq.
Founding Partner, Baker & McKenzie - CIS, Limited, Moscow, Russia

Laura Nassar
Head of Compliance, Middle East, Roche Pharmaceuticals, Dubai, UAE

John Patrick Oroho, Esq.
Executive Vice President and Chief Strategy Officer, Porzio Life Sciences, LLC, Principal, Porzio, Bromberg & Newman PC, Morristown, NJ, USA

David O'Shaughnessy
Vice President, Compliance, Emerging Markets, Quintiles, Board Member, ETHICS, Former Vice President Compliance, International Pharmaceuticals, GSK, Former Vice President, Global Compliance Strategy, AstraZeneca, Reading, UK

Maria-Teresa Rico Pérez, MD
Europe and Canada Regional Compliance Officer, Biogen, Zug, Switzerland

Marie-Claire Pickaert, MA
Deputy Director General, Chief Financial Officer and Ambassador to the Medical Communities, European Federation of Pharmaceutical Industries and Associations (EFPIA), Brussels, Belgium

Ariadna Quesada, MPP
Compliance Manager Europe, Middle-East and Africa, MicroPort Orthopedics Inc., Amsterdam, Netherlands

Uffe Kåre Rasmussen, MSc
Senior Director and Chief Compliance Officer, H. Lundbeck A/S, Former Principal Scientist, Novo Nordisk A/S,, Copenhagen, Denmark

Vivian Robinson, Esq.
Queen's Counsel, Partner, McGuire Woods, London, UK

Hubertus Stockmann, MBA
Divisional Compliance Officer, Merck KgaA, Frankfurt, Germany

Mariusz Witalis
Partner, Fraud Investigation and Dispute Services, Ernst & Young LLP, Warsaw, Poland

Elisabethann Wright, Esq.
Partner, Hogan Lovells International LLP, Brussels, Belgium

Jolanta Wyszynska
Vice President, Compliance Europe, AstraZeneca, Warsaw, Poland

Jose F. Zamarriego Izquierdo
Director Unidad de Supervision Deontologica, Farmainidustria, Madrid, Spain

2016-2017 GLOBAL PHARMA COMPLIANCE CONGRESSES

ELEVENTH INTERNATIONAL PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
Sponsored by International Society of Healthcare Compliance Professionals (ETHICS)
Cosponsored by Pharmaceutical Compliance Forum (PCF)
May 15 - 17, 2017
Lisbon Marriott Hotel
Lisbon, Portugal
www.InternationalPharmaCongress.com
EIGHTEENTH ANNUAL PHARMACEUTICAL AND MEDICAL DEVICE COMPLIANCE CONGRESS
A Hybrid Conference and Internet Event
Sponsored by Pharmaceutical Compliance Forum
November 6 - 8, 2017
Mandarin Oriental
Washington, DC
www.PharmaCongress.com
SEVENTH ASIA PACIFIC PHARMACEUTICAL AND
MEDICAL DEVICE COMPLIANCE CONGRESS

Sponsored by Asia Pacific Healthcare Industry Compliance Team
Cosponsored by International Society of Healthcare Ethics and Compliance Professionals (ETHICS) and Pharmaceutical Compliance Forum (PCF)
September 13 - 15, 2017
InterContinental Shanghai, Shanghai, China
www.AsianPharmaCongress.com


SPONSORED BY:



CO-SPONSORED BY:



KEYNOTE SPEAKERS

Nicola Bonucci, DEA,
DESS, LLM

Director, Directorate for Legal Affairs, OECD, Paris, France

Heitor Costa
Executive Director, Portuguese Association of the Pharmaceutical Industry, (APIFARMA), Lisbon, Portugal

Tarek Helou, Esq.
Assistant Chief, FCPA Unit, Fraud Section, Criminal Division, U.S. Department of Justice, Washington, DC, USA

Sophie Peresson, LLM, MSc
Global Health Policy Director, Pharmaceuticals & Healthcare Programme, Transparency International UK, Former Regional Director, International Diabetes Federation European Region, Former Communications and Advocacy Manager, European Council on Refugees and Exiles, London, UK

Marie-Claire Pickaert
Deputy Director General, Chief Financial Officer and Ambassador to the Medical Communities, European Federation of Pharmaceutical Industries and Associations (EFPIA), Brussels, Belgium

Aleksandar Rusanov, Esq.
Legal Advisor, Legal Department, European Medicines Agency (EMA), London, United Kingdom


Neill Stansbury, Esq.
Co-founder and Director of the Global Infrastructure Anti-Corruption Centre, Chair, International Organization for Standardization Anti-Bribery Project Committee, Vice Chair, Anti-corruption Standing Committee, World Federation of Engineering Organization, Buckinghamshire, UK

GRANTORS:
BRONZE






MEDIA PARTNER


FOLLOW INTERNATIONAL PHARMA CONGRESS ON




Tweet using #PharmaCongress

INTERNATIONAL PHARMA CONGRESS IS
ONSITE ATTENDANCE
Simply register, travel to the conference city and attend in person.

Pros: subject matter immersion; professional networking opportunities; faculty interaction



OTHER INTERNATIONAL PHARMA CONGRESSES

2007 - Brussels


2008 - Paris


2009 - Rome


2010 - Berlin


2011 - Istanbul


2011 - Singapore


2012 - Budapest


2012 - Shanghai


2012 - São Paulo


2013 - Madrid, Spain


2013 - Kuala Lumpur


2014 - Dubai


2014 - Mexico City


2014 - Mexico City


2014 - Shanghai


2015 - Manila


2016 - Warsaw




We subscribe to the HONcode principles of the HON Foundation. Click to verify.




CONGRESS REGISTRATION

For Congress registration information, visit www.InternationalPharmaCongress.com/registration.php, email registration@hcconferences.com, or call 800-503-8171.


CONGRESS EXHIBIT & SPONSORSHIP INFORMATION
For sponsorship and exhibit information, visit www.internationalpharmacongress.com/promotional/index.html, or contact Justin Sorensen, Exhibit Manager, at 206-452-0609 phone, 206-319-5303 fax, or exhibits@hcconferences.com.